Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394615 · ClinicalTrials.gov registry record · NA
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00394615: Clinical Trial NA study, sponsored by Stanford University.
NCT00394615 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394615, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
In this research study of metabolic imaging in locally advanced rectal cancer, we hope to learn whether new medical imaging technology can help predict the response of rectal cancer to preoperative chemotherapy and radiation therapy. Ultimately we hope this information will in the future help us predict which patients will benefit from more or less aggressive initial therapy for their rectal cancer.
Interventions
- PROCEDURE Metabolic Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394615
The ClinicalTrials.gov registry entry for NCT00394615 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metabolic Imaging is the first listed.
NCT00394615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394615 about?
NCT00394615 is a clinical study titled "Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA". In this research study of metabolic imaging in locally advanced rectal cancer, we hope to learn whether new medical imaging technology can help predict the response of rectal cancer to preoperative chemotherapy and radiation therapy. Ultimately we hope this information will in the future help us pre...
What is the current status of trial NCT00394615?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2003-10. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00394615?
The interventions under investigation include: Metabolic Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00394615?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.